Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.138 EUR | +2.06% |
|
-1.74% | -25.90% |
06-27 | Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness | CI |
05-21 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.90% | 35.25M | |
+15.82% | 122B | |
+20.35% | 114B | |
+18.43% | 25.71B | |
-25.31% | 19.02B | |
-20.77% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Appoints Axel Malkomes as Cfo, Effective from April 1, 2019